This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vallis, A. J.
Right arrow Articles by Frank, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vallis, A. J.
Right arrow Articles by Frank, D. W.

 Previous Article  |  Next Article 

Infection and Immunity, April 1999, p. 2040-2044, Vol. 67, No. 4
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Biological Effects of Pseudomonas aeruginosa Type III-Secreted Proteins on CHO Cells

Amy J. Vallis, Viviane Finck-Barbançon, Timothy L. Yahr, and Dara W. Frank*

Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin 53226

Received 9 December 1998/Accepted 6 January 1999


    ABSTRACT
Top
Abstract
Text
References

A strain of Pseudomonas aeruginosa that fails to express known type III-secreted effector proteins was constructed as an expression host. Individual effectors were expressed in trans, and their biological effects on CHO cells were assessed in an acute cellular infection model. Intoxication with ExoS, ExoT, or ExoY resulted in alterations in cell morphology. As shown in previous genetic studies, ExoU expression was linked to acute cytotoxicity.


    TEXT
Top
Abstract
Text
References

The exoenzyme S regulon, which encodes the type III secretion system of Pseudomonas aeruginosa, consists of coordinately regulated secretion, translocation, regulatory, and effector genes (6). To date, four type III-secreted effector proteins have been identified; ExoS, ExoT, ExoU, and ExoY (3, 10, 21-23). ExoS and ExoT are members of the family of bacterial ADP-ribosyltransferases (10, 21). Despite having 75% amino acid identity, ExoT possesses only 0.2% of the enzymatic activity of ExoS (21). ExoU functions as an acute cytotoxin in vitro and is associated with lung injury in vivo (3). The mechanism of ExoU-mediated toxicity remains unknown. ExoY is a recently discovered adenylate cyclase, which is activated by a eukaryotic protein that is distinct from calmodulin (23). Because P. aeruginosa produces multiple effector proteins in a strain-specific manner, it is difficult to determine the role of the individual products in pathogenesis. The goal of this study was to construct a strain of P. aeruginosa which fails to express the known effector proteins for use as an expression host. By constructing a host without effectors but possessing a functional secretion and delivery apparatus, the cellular effects of individual virulence determinants could be assessed.

Construction of a P. aeruginosa type III-secreted effector mutant. P. aeruginosa PA103 was chosen as the parental strain (Table 1). PA103 produces significant amounts of ExoU and ExoT (3) but fails to express ExoY (23) and does not possess exoS (5). In addition, strain PA103 is easy to genetically manipulate and displays virulence in both tissue culture and acute lung infection models of P. aeruginosa pathogenesis (1, 3, 5, 11). Although strain PA103 produces large amounts of exotoxin A in vitro, this toxin appears to play no role in the tissue culture and acute infection models developed to measure the contribution of the type III-secreted products (1, 11). In previous studies, individual mutations in exoU (PA103Delta exoU) and exoT (PA103exoT::Tc) were constructed (3, 4). In this study, we constructed the double mutant PA103Delta exoUexoT::Tc and compared its properties with those of the parental (PA103) and individual mutant (PA103Delta exoU and PA103exoT::Tc) strains in a Chinese hamster ovary (CHO) cell model of infection.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   Bacterial strains and plasmids

To construct the double exoU-exoT mutation, pMOBexoT::Tc (3) was conjugated into strain PA103Delta exoU (4). Tetracycline-resistant merodiploids were selected and passaged on Vogel-Bonner minimal medium (20) with 100 µg of tetracycline per ml. Plasmid sequences and the wild-type exoT allele were resolved from the chromosome by selecting for strains resistant to 5% sucrose and tetracycline (7, 18). Isolates exhibiting the correct phenotype were grown under inducing conditions for the exoenzyme S regulon, and their extracellular protein profiles were determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Coomassie blue staining. Chromosomal DNA was isolated (7) from strains defective for the extracellular production of ExoU and ExoT and subjected to Southern blot analysis (14). We selected a single isolate, PA103Delta exoUexoT::Tc, which failed to hybridize to the exoU probe, exhibited tetracycline resistance, and failed to express extracellular ExoU and ExoT.

Single (PA103exoT::Tc and PA103Delta exoU) and double (PA103Delta exoUexoT::Tc) mutant strains were analyzed for their extracellular protein profiles by SDS-PAGE and Western blot analysis. In the parental PA103 strain, all of the tested extracellular proteins of the regulon (ExoU, ExoT, PcrV, and PopD) were induced by the inclusion of the chelator nitrilotriacetic acid (NTA) in the growth medium (Fig. 1A and B). Induction and secretion of type III proteins also occurred in each mutant strain. These results indicated that type III-mediated regulation and secretion were unaffected by the introduction of mutant alleles. Introduction of either single or double mutant alleles resulted in the absence of only the respective protein products (Fig. 1A and B).


View larger version (62K):
[in this window]
[in a new window]
  		FIG. 1.   Extracellular protein profiles, Western blot analysis, and infection of CHO cells with parental (PA103) and mutant (PA103Delta exoU, PA103exoT::Tc, and PA103Delta exoUexoT::Tc) strains of P. aeruginosa. (A) Coomassie blue-stained polyacrylamide gel (10%) of concentrated culture supernatants from strains grown in the absence (lanes 1, 3, 5, and 7) or presence (lanes 2, 4, 6, and 8) of 10 mM NTA, a chelator that induces the expression of the exoenzyme S regulon. Supernatant fractions were collected and concentrated 20-fold by the addition of a saturated ammonium sulfate solution to 55% from strains PA103 (lanes 1 and 2), PA103Delta exoU (lanes 3 and 4), PA103exoT::Tc (lanes 5 and 6), and PA103Delta exoUexoT::Tc (lanes 7 and 8). Molecular mass markers (MWM; in kilodaltons) and the relative mobilities of ExoU (72 kDa), ExoT (53 kDa), PcrV (32.2 kDa), and PopD (31 kDa) are indicated. (B) Western blot of a duplicate gel as shown in panel A. A mixture of specific antisera reactive to ExoU, ExoS-ExoT, PcrV, and PopD was used as the primary antibody. Bound antibodies were visualized with a peroxidase-labeled secondary antibody and 4-chloro-1-naphthol and peroxide as substrate. (C) Phase-contrast microscopy (40× objective) of CHO cell morphology following infection with parental or mutant strains of P. aeruginosa. The results of the trypan blue staining for uninfected cells, PA103, and PA103exoT::Tc (10× objective) are shown in the insets. Only infections with bacterial strains expressing ExoU resulted in trypan blue staining 3 to 4 h after bacterial infection.

Parental and mutant P. aeruginosa strains were transferred from Vogel-Bonner minimal medium to serum-free tissue culture medium and used to infect CHO cells at a multiplicity of infection of approx 5:1. Following either a 3-h (strains PA103 and PA103exoT::Tc) or a 4-h (uninfected; strains PA103Delta exoU and PA103Delta exoUexoT::Tc) infection at 37°C in 5% CO2, duplicate wells were washed with phosphate-buffered saline and either fixed in 2% paraformaldehyde or stained for 5 min with trypan blue and photographed. An additional quantitative 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay for cell viability was performed for each strain 4 h postinfection (2). CHO cells infected with parental strain PA103 differed in morphology, were permeable to trypan blue, and showed significant differences in cell viability compared to uninfected cells (Fig. 1C and Table 2). CHO cells infected with PA103Delta exoU (expressing ExoT) appeared rounded, were not permeable to trypan blue, and retained viability (Fig. 1C and Table 2). Cells infected with a strain expressing only ExoU (PA103exoT::Tc) possessed a phenotype similar to that of cells infected with the parental strain. Finally, when a strain of P. aeruginosa which fails to express any of the known type III-secreted effector proteins, PA103Delta exoUexoT::Tc, was used, the infected cells were indistinguishable from the uninfected control cells (Fig. 1C and Table 2). We interpreted these results as suggesting that part of the ExoU-mediated cytotoxic response (3) may involve cellular morphology changes and/or membrane damage. On the other hand, ExoT appears to cause cell rounding in the absence of membrane damage or changes in cell viability at this time point. Elimination of ExoT and ExoU appears to result in an avirulent strain in this tissue culture model.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 2.   Biological effects of the various bacterial strains on CHO cells

Expression of individual effector proteins in PA103Delta exoUexoT::Tc. In the acute in vitro infection model, cocultivation of strain PA103Delta exoUexoT::Tc with CHO cells resulted in no observable effect. This result suggested that this might be an ideal host strain from which to assess the biological effects of the individual type III-secreted effector proteins of P. aeruginosa. Strain PA103Delta exoUexoT::Tc was transformed with a vector control (pUCP18); pUCPexoS, a plasmid encoding a noncatalytic derivative of ExoS (pUCPexoSE381A); pUCPexoT; pUCPexoY; or a plasmid expressing a noncatalytic adenylate cyclase (pUCPexoYK81M). Expression plasmid pUCPexoSE381A was constructed by replacing the NsiI-BamHI fragment of pUCP18exoS (12) with that from pET16bDelta RIexoSE381A (13). The strains were induced for expression of the exoenzyme S regulon, and the extracellular protein profile was analyzed by SDS-PAGE and Western blot analysis (Fig. 2A and B). This analysis indicated that expression of each product was variable. ExoS and the noncatalytic mutant ExoSE381A appeared to be equally expressed and secreted, as has been shown in previous studies (Fig. 2A and B, compare lanes 2 and 3) (22). When exoT was provided in trans, the protein was made and secreted in relatively large quantities (Fig. 2A and B, lanes 5). Both forms of ExoY were expressed and secreted in much smaller quantities than either ExoS or ExoT.


View larger version (62K):
[in this window]
[in a new window]
  		FIG. 2.   Extracellular protein profiles and Western blot analysis of PA103Delta exoUexoT::Tc expressing various effector proteins in trans and their effects on CHO cells. (A) Coomassie blue-stained polyacrylamide gel (11%) of concentrated culture supernatants from strains grown under inducing conditions (growth in the presence of 10 mM NTA). Supernatants are from strains PA103Delta exoUexoT::Tc pUCP18 (lane 1), PA103Delta exoUexoT::Tc pUCPexoS (lane 2), PA103Delta exoUexoT::Tc pUCPexoSE381A (lane 3), PA103Delta exoUexoT::Tc pUCPexoT (lane 4), PA103Delta exoUexoT::Tc pUCPexoY (lane 5), and PA103Delta exoUexoT::Tc pUCPexoYK81M (lane 6). Molecular mass markers (MWM; in kilodaltons) and the relative mobilities of ExoT (53 kDa), ExoS (49 kDa), and ExoY (42 kDa) are indicated. (B) Western blot of a duplicate gel as shown in panel A. A mixture of specific antisera to ExoS-ExoT and ExoY was used, and the bound antibodies were visualized with a peroxidase-labeled secondary antibody. (C) Cellular morphology of CHO cells infected with PA103Delta exoUexoT::Tc expressing various effector proteins in trans. The name of the expression plasmid in each strain is given above the appropriate picture.

CHO cells were infected for 4 h and subsequently stained with trypan blue or fixed in paraformaldehyde and observed by phase-contrast microscopy or subjected to the MTT assay. At this point in infection, permeability to trypan blue or changes in cell viability were not observed with strains expressing ExoS, ExoSE381A, ExoT, ExoY, or ExoYK81M (Table 2). Compared to the vector control, however, expression of ExoS, ExoSE381A, ExoT, and ExoY, but not of ExoYK81M, resulted in an altered cellular morphology (Fig. 2C and Table 2). Cells appeared rounded and eventually detached from the surface of the well. Our data confirm that the ADP-ribosyltransferase activity of either ExoS or ExoT is not required to cause a rounding of CHO cells, supporting earlier observations of HeLa cell morphology changes when ExoS and ExoSE381A were delivered by the Yersinia type III apparatus (8). In addition, we confirm that ExoY is capable of causing a similar morphological effect on CHO cells which is dependent on adenylate cyclase activity (23). As positive controls for cell morphological changes, CHO cells were intoxicated with Escherichia coli heat-labile enterotoxin or pertussis toxin. Heat-labile enterotoxin mediated CHO cell elongation while pertussis toxin mediated CHO cell clustering, indicating that the cell line we are using responds to changes in cyclic AMP levels as previously reported (data not shown) (9, 23).

Measurement of effector translocation into CHO cells. In previous studies, we have used ExoS ADP-ribosyltransferase activity to measure type III-mediated translocation from P. aeruginosa 388 (expresses ExoS and ExoT) into CHO cells (19). To determine if PA103Delta exoUexoT::Tc could be used to study translocation of individual components, we pretreated CHO cells with cytochalasin D to inhibit the uptake of bacteria. Treated cells were infected with an inoculum of PA103Delta exoUexoT::Tc pUCPexoS in serum-free medium for 4 h at a multiplicity of infection of approx 5:1. The supernatant was removed, the number of viable bacteria was measured from a small aliquot, and the remaining sample was subjected to centrifugation at 14,000 × g, 4°C. A portion of the soluble fraction was retained for ADP-ribosyltransferase activity assays (supernatant-associated activity). The CHO cell monolayer was washed and treated for 2 h with 100 µg of ciprofloxacin per ml and 200 µg of gentamicin per ml to kill the extracellular bacteria. Infected CHO cells were lysed with 150 µl of distilled water. The lysate was subjected to centrifugation at 14,000 × g (4°C), and a portion of the soluble fraction was retained to perform ADP-ribosyltransferase activity assays (lysate-associated activity) as described previously (19). A duplicate well, not treated with antibiotics, was used to perform viable counts. Supernatant and lysate fractions from uninfected CHO cells or cells infected with strains containing the vector control plasmid (pUCP18), pUCPexoSE381A, or pUCPexoT were included as negative controls. Under these conditions, ExoS ADP-ribosyltransferase activity was predominantly associated with the CHO cell lysate, rather than the supernatant, indicating that PA103Delta exoUexoT::Tc is able to translocate ExoS (Fig. 3). Similar results were obtained when CHO cells were infected with PA103Delta exoUexoT::Tc pUCPexoY and cyclic AMP accumulation was measured (23). Activities that were slightly above background levels were measured from cells infected with strains expressing either ExoSE381A or ExoT. This amount of activity may represent the residual ADP-ribosyltransferase activity of the mutant proteins.


View larger version (19K):
[in this window]
[in a new window]
  		FIG. 3.   Cell- and supernatant-associated ADP-ribosyltransferase activity of PA103Delta exoUexoT::Tc expressing ExoS, ExoSE381A, or ExoT in trans. ADP-ribosyltransferase activity assays were performed on supernatant- and cell-associated samples collected from uninfected CHO cells or CHO cells infected with PA103Delta exoUexoT::Tc pUCP18, PA103Delta exoUexoT::Tc pUCPexoS, PA103Delta exoUexoT::Tc pUCPexoSE381A, or PA103exoUexoT::Tc pUCPexoT. Activity is normalized to CFU and expressed as 10-4 femtomoles of ADPRT (femtomoles of ADP-ribose transferred to soybean trypsin inhibitor).

Concluding remarks. We constructed a strain of P. aeruginosa, PA103Delta exoUexoT::Tc, which fails to express any of the known P. aeruginosa type III-secreted effector proteins. Strain PA103Delta exoUexoT::Tc was used as an expression host, and the effects of individual translocated proteins were assessed in a cellular acute infection model. CHO cell viability was measured by using trypan blue staining and an MTT assay. Our results indicate that PA103Delta exoUexoT::Tc expresses and secretes type III effectors and that translocation into CHO cells is measurable by using either activity assays or changes in cell morphology or viability. Our analysis confirmed that ExoS, ExoSE381A, and ExoY alter CHO cell morphology but do not result in an acute cytotoxic response. ExoS, however, has been shown to mediate cytotoxic responses after longer infection (15) or transfection (16) periods. We demonstrated that delivery of ExoT also results in morphology changes and confirmed that ExoU is responsible for acute cytotoxicity. The biological effects of each of the type III-secreted effectors are summarized in Table 3.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 3.   Biological effects of P. aeruginosa type III-secreted proteins on CHO cells


    ACKNOWLEDGMENTS

This work was supported by grants AI-31665 and AI-01289 to D.W.F. from the National Institute of Allergy and Infectious Diseases, National Institutes of Health.


    FOOTNOTES

* Corresponding author. Mailing address: Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226. Phone: (414) 456-8766. Fax: (414) 456-6535. E-mail: frankd{at}post.its.mcw.edu.

Editor:   D. L. Burns


    REFERENCES
Top
Abstract
Text
References

1. Apodaca, G., M. Bomsel, R. Lindstedt, J. Engel, D. Frank, K. Mostov, and J. Wiener-Kronish. 1995. Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing. Infect. Immun. 63:1541-1551[Abstract].
2. Denizot, F., and R. Lang. 1986. Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89:271-277[Medline].
3. Finck-Barbançon, V., J. Goranson, L. Zhu, T. Sawa, J. P. Wiener-Kronish, S. M. J. Fleiszig, C. Wu, L. Mende-Mueller, and D. W. Frank. 1997. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol. Microbiol. 25:547-557[Medline].
4. Finck-Barbançon, V., T. L. Yahr, and D. W. Frank. 1998. Identification and characterization of SpcU, a chaperone required for efficient secretion of the ExoU cytotoxin. J. Bacteriol. 180:6224-6231[Abstract/Free Full Text].
5. Fleiszig, S. M. J., J. P. Wiener-Kronish, H. Miyazaki, V. Vallas, K. E. Mostov, D. Kanada, T. Sawa, T. S. B. Yen, and D. W. Frank. 1997. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect. Immun. 65:579-586[Abstract].
6. Frank, D. W. 1997. The exoenzyme S regulon of Pseudomonas aeruginosa. Mol. Microbiol. 26:621-629[Medline].
7. Frank, D. W., G. Nair, and H. P. Schweizer. 1994. Construction and characterization of chromosomal insertional mutations of the Pseudomonas aeruginosa exoenzyme S trans-regulatory locus. Infect. Immun. 62:554-563[Abstract/Free Full Text].
8. Frithz-Lindsten, E., Y. Du, R. Rosqvist, and Å. Forsberg. 1997. Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity, and disruption of actin microfilaments. Mol. Microbiol. 25:1125-1139[Medline].
9. Hewlett, E. L., K. T. Sauer, G. A. Myers, J. L. Cowell, and R. L. Guerrant. 1983. Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect. Immun. 40:1198-1203[Abstract/Free Full Text].
10. Iglewski, B. H., J. Sadoff, M. J. Bjorn, and E. S. Maxwell. 1978. Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A. Proc. Natl. Acad. Sci. USA 75:3211-3215[Abstract/Free Full Text].
11. Kudoh, I., J. P. Wiener-Kronish, S. Hashimoto, J. Pittet, and D. W. Frank. 1994. Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury. Am. J. Physiol. (Lung Cell Mol. Physiol.) 11:L551-L556.
12. Kulich, S. M., D. W. Frank, and J. T. Barbieri. 1995. Expression of recombinant exoenzyme S of Pseudomonas aeruginosa. Infect. Immun. 63:1-8[Abstract].
13. Liu, S., S. M. Kulich, and J. T. Barbieri. 1996. Identification of glutamic acid 381 as a candidate active site residue of Pseudomonas aeruginosa exoenzyme S. Biochemistry 35:2754-2758[Medline].
14. Maniatis, T., E. F. Fritsch, and H. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
15. Olson, J., E. M. McGuffie, and D. W. Frank. 1997. Effects of differential expression of the 49-kilodalton exoenzyme S by Pseudomonas aeruginosa on cultured eukaryotic cells. Infect. Immun. 65:248-256[Abstract].
16. Pederson, K. J., and J. T. Barbieri. 1998. Intracellular expression of the ADP-ribosyltransferase domain of Pseudomonas aeruginosa. Mol. Microbiol. 30:751-759[Medline].
17. Schweizer, H. P. 1991. Escherichia-Pseudomonas shuttle vectors derived from pUC18/19. Gene 97:109-121[Medline].
18. Schweizer, H. P. 1992. Allelic exchange in Pseudomonas aeruginosa using novel ColE1-type vectors and a family of cassettes containing a portable oriT and the counter-selectable Bacillus subtilis sacB marker. Mol. Microbiol. 6:1195-1204[Medline].
19. Vallis, A., T. L. Yahr, J. T. Barbieri, and D. W. Frank. 1999. Regulation of ExoS production and secretion by Pseudomonas aeruginosa in response to tissue culture conditions. Infect. Immun. 67:914-920[Abstract/Free Full Text].
20. Vogel, H. J., and D. M. Bonner. 1956. Acetylornithase of Escherichia coli: partial purification and some properties. J. Biol. Chem. 218:97-106[Free Full Text].
21. Yahr, T. L., J. T. Barbieri, and D. W. Frank. 1996. Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa. J. Bacteriol. 178:1412-1419[Abstract/Free Full Text].
22. Yahr, T. L., J. Goranson, and D. W. Frank. 1996. Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway. Mol. Microbiol. 22:991-1003[Medline].
23. Yahr, T. L., A. J. Vallis, M. K. Hancock, J. T. Barbieri, and D. W. Frank. 1998. ExoY, a novel adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc. Natl. Acad. Sci. USA 95:13899-13904[Abstract/Free Full Text].

Infection and Immunity, April 1999, p. 2040-2044, Vol. 67, No. 4
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Rao, A. R., Laxova, A., Farrell, P. M., Barbieri, J. T. (2009). Proteomic Identification of OprL as a Seromarker for Initial Diagnosis of Pseudomonas aeruginosa Infection of Patients with Cystic Fibrosis. J. Clin. Microbiol. 47: 2483-2488 [Abstract] [Full Text]  
  • Baer, M., Sawa, T., Flynn, P., Luehrsen, K., Martinez, D., Wiener-Kronish, J. P., Yarranton, G., Bebbington, C. (2009). An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity. Infect. Immun. 77: 1083-1090 [Abstract] [Full Text]  
  • Diaz, M. H., Shaver, C. M., King, J. D., Musunuri, S., Kazzaz, J. A., Hauser, A. R. (2008). Pseudomonas aeruginosa Induces Localized Immunosuppression during Pneumonia. Infect. Immun. 76: 4414-4421 [Abstract] [Full Text]  
  • El Solh, A. A., Akinnusi, M. E., Wiener-Kronish, J. P., Lynch, S. V., Pineda, L. A., Szarpa, K. (2008). Persistent Infection with Pseudomonas aeruginosa in Ventilator-associated Pneumonia. Am. J. Respir. Crit. Care Med. 178: 513-519 [Abstract] [Full Text]  
  • Angus, A. A., Lee, A. A., Augustin, D. K., Lee, E. J., Evans, D. J., Fleiszig, S. M. J. (2008). Pseudomonas aeruginosa Induces Membrane Blebs in Epithelial Cells, Which Are Utilized as a Niche for Intracellular Replication and Motility. Infect. Immun. 76: 1992-2001 [Abstract] [Full Text]  
  • Zaidi, T., Bajmoczi, M., Zaidi, T., Golan, D. E., Pier, G. B. (2008). Disruption of CFTR-Dependent Lipid Rafts Reduces Bacterial Levels and Corneal Disease in a Murine Model of Pseudomonas aeruginosa Keratitis. IOVS 49: 1000-1009 [Abstract] [Full Text]  
  • Coutard, F., Lozach, S., Pommepuy, M., Hervio-Heath, D. (2007). Real-Time Reverse Transcription-PCR for Transcriptional Expression Analysis of Virulence and Housekeeping Genes in Viable but Nonculturable Vibrio parahaemolyticus after Recovery of Culturability. Appl. Environ. Microbiol. 73: 5183-5189 [Abstract] [Full Text]  
  • Lee, V. T., Pukatzki, S., Sato, H., Kikawada, E., Kazimirova, A. A., Huang, J., Li, X., Arm, J. P., Frank, D. W., Lory, S. (2007). Pseudolipasin A Is a Specific Inhibitor for Phospholipase A2 Activity of Pseudomonas aeruginosa Cytotoxin ExoU. Infect. Immun. 75: 1089-1098 [Abstract] [Full Text]  
  • Zolfaghar, I., Evans, D. J., Ronaghi, R., Fleiszig, S. M. J. (2006). Type III Secretion-Dependent Modulation of Innate Immunity as One of Multiple Factors Regulated by Pseudomonas aeruginosa RetS. Infect. Immun. 74: 3880-3889 [Abstract] [Full Text]  
  • Cuzick, A., Stirling, F. R., Lindsay, S. L., Evans, T. J. (2006). The Type III Pseudomonal Exotoxin U Activates the c-Jun NH2-Terminal Kinase Pathway and Increases Human Epithelial Interleukin-8 Production. Infect. Immun. 74: 4104-4113 [Abstract] [Full Text]  
  • Shen, D. K., Filopon, D., Kuhn, L., Polack, B., Toussaint, B. (2006). PsrA Is a Positive Transcriptional Regulator of the Type III Secretion System in Pseudomonas aeruginosa. Infect. Immun. 74: 1121-1129 [Abstract] [Full Text]  
  • Shaver, C. M., Hauser, A. R. (2006). Interactions between effector proteins of the Pseudomonas aeruginosa type III secretion system do not significantly affect several measures of disease severity in mammals. Microbiology 152: 143-152 [Abstract] [Full Text]  
  • Rocha, C. L., Rucks, E. A., Vincent, D. M., Olson, J. C. (2005). Examination of the Coordinate Effects of Pseudomonas aeruginosa ExoS on Rac1. Infect. Immun. 73: 5458-5467 [Abstract] [Full Text]  
  • Corech, R., Rao, A., Laxova, A., Moss, J., Rock, M. J., Li, Z., Kosorok, M. R., Splaingard, M. L., Farrell, P. M., Barbieri, J. T. (2005). Early Immune Response to the Components of the Type III System of Pseudomonas aeruginosa in Children with Cystic Fibrosis. J. Clin. Microbiol. 43: 3956-3962 [Abstract] [Full Text]  
  • Lee, V. T., Smith, R. S., Tummler, B., Lory, S. (2005). Activities of Pseudomonas aeruginosa Effectors Secreted by the Type III Secretion System In Vitro and during Infection. Infect. Immun. 73: 1695-1705 [Abstract] [Full Text]  
  • Rabin, S. D. P., Hauser, A. R. (2005). Functional Regions of the Pseudomonas aeruginosa Cytotoxin ExoU. Infect. Immun. 73: 573-582 [Abstract] [Full Text]  
  • Rucks, E. A., Olson, J. C. (2005). Characterization of an ExoS Type III Translocation-Resistant Cell Line. Infect. Immun. 73: 638-643 [Abstract] [Full Text]  
  • Jain, M., Ramirez, D., Seshadri, R., Cullina, J. F., Powers, C. A., Schulert, G. S., Bar-Meir, M., Sullivan, C. L., McColley, S. A., Hauser, A. R. (2004). Type III Secretion Phenotypes of Pseudomonas aeruginosa Strains Change during Infection of Individuals with Cystic Fibrosis. J. Clin. Microbiol. 42: 5229-5237 [Abstract] [Full Text]  
  • Goure, J., Pastor, A., Faudry, E., Chabert, J., Dessen, A., Attree, I. (2004). The V Antigen of Pseudomonas aeruginosa Is Required for Assembly of the Functional PopB/PopD Translocation Pore in Host Cell Membranes. Infect. Immun. 72: 4741-4750 [Abstract] [Full Text]  
  • Sayner, S. L., Frank, D. W., King, J., Chen, H., VandeWaa, J., Stevens, T. (2004). Paradoxical cAMP-Induced Lung Endothelial Hyperpermeability Revealed by Pseudomonas aeruginosa ExoY. Circ. Res. 95: 196-203 [Abstract] [Full Text]  
  • Garrity-Ryan, L., Shafikhani, S., Balachandran, P., Nguyen, L., Oza, J., Jakobsen, T., Sargent, J., Fang, X., Cordwell, S., Matthay, M. A., Engel, J. N. (2004). The ADP Ribosyltransferase Domain of Pseudomonas aeruginosa ExoT Contributes to Its Biological Activities. Infect. Immun. 72: 546-558 [Abstract] [Full Text]  
  • Rocha, C. L., Coburn, J., Rucks, E. A., Olson, J. C. (2003). Characterization of Pseudomonas aeruginosa Exoenzyme S as a Bifunctional Enzyme in J774A.1 Macrophages. Infect. Immun. 71: 5296-5305 [Abstract] [Full Text]  
  • Lee, E. J., Cowell, B. A., Evans, D. J., Fleiszig, S. M. J. (2003). Contribution of ExsA-Regulated Factors to Corneal Infection by Cytotoxic and Invasive Pseudomonas aeruginosa in a Murine Scarification Model. IOVS 44: 3892-3898 [Abstract] [Full Text]  
  • Ajayi, T., Allmond, L. R., Sawa, T., Wiener-Kronish, J. P. (2003). Single-Nucleotide-Polymorphism Mapping of the Pseudomonas aeruginosa Type III Secretion Toxins for Development of a Diagnostic Multiplex PCR System. J. Clin. Microbiol. 41: 3526-3531 [Abstract] [Full Text]  
  • Rabin, S. D. P., Hauser, A. R. (2003). Pseudomonas aeruginosa ExoU, a Toxin Transported by the Type III Secretion System, Kills Saccharomyces cerevisiae. Infect. Immun. 71: 4144-4150 [Abstract] [Full Text]  
  • Jia, J., Alaoui-El-Azher, M., Chow, M., Chambers, T. C., Baker, H., Jin, S. (2003). c-Jun NH2-Terminal Kinase-Mediated Signaling Is Essential for Pseudomonas aeruginosa ExoS-Induced Apoptosis. Infect. Immun. 71: 3361-3370 [Abstract] [Full Text]  
  • Miyata, S., Casey, M., Frank, D. W., Ausubel, F. M., Drenkard, E. (2003). Use of the Galleria mellonella Caterpillar as a Model Host To Study the Role of the Type III Secretion System in Pseudomonas aeruginosa Pathogenesis. Infect. Immun. 71: 2404-2413 [Abstract] [Full Text]  
  • Ha, U.-H., Wang, Y., Jin, S. (2003). DsbA of Pseudomonas aeruginosa Is Essential for Multiple Virulence Factors. Infect. Immun. 71: 1590-1595 [Abstract] [Full Text]  
  • Jacob, T., Lee, R. J., Engel, J. N., Machen, T. E. (2002). Modulation of Cytosolic Ca2+ Concentration in Airway Epithelial Cells by Pseudomonas aeruginosa. Infect. Immun. 70: 6399-6408 [Abstract] [Full Text]  
  • Riese, M. J., Goehring, U.-M., Ehrmantraut, M. E., Moss, J., Barbieri, J. T., Aktories, K., Schmidt, G. (2002). Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS. J. Biol. Chem. 277: 12082-12088 [Abstract] [Full Text]  
  • Feltman, H., Schulert, G., Khan, S., Jain, M., Peterson, L., Hauser, A. R. (2001). Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 147: 2659-2669 [Abstract] [Full Text]  
  • Fraylick, J. E., La Rocque, J. R., Vincent, T. S., Olson, J. C. (2001). Independent and Coordinate Effects of ADP-Ribosyltransferase and GTPase-Activating Activities of Exoenzyme S on HT-29 Epithelial Cell Function. Infect. Immun. 69: 5318-5328 [Abstract] [Full Text]  
  • Finck-Barbancon, V., Frank, D. W. (2001). Multiple Domains Are Required for the Toxic Activity of Pseudomonas aeruginosa ExoU. J. Bacteriol. 183: 4330-4344 [Abstract] [Full Text]  
  • Ha, U., Jin, S. (2001). Growth Phase-Dependent Invasion of Pseudomonas aeruginosa and Its Survival within HeLa Cells. Infect. Immun. 69: 4398-4406 [Abstract] [Full Text]  
  • Jendrossek, V., Grassme, H., Mueller, I., Lang, F., Gulbins, E. (2001). Pseudomonas aeruginosa-Induced Apoptosis Involves Mitochondria and Stress-Activated Protein Kinases. Infect. Immun. 69: 2675-2683 [Abstract] [Full Text]  
  • Moss, J., Ehrmantraut, M. E., Banwart, B. D., Frank, D. W., Barbieri, J. T. (2001). Sera from Adult Patients with Cystic Fibrosis Contain Antibodies to Pseudomonas aeruginosa Type III Apparatus. Infect. Immun. 69: 1185-1188 [Abstract] [Full Text]  
  • WINSTANLEY, C., HART, C. A. (2001). Type III secretion systems and pathogenicity islands. J Med Microbiol 50: 116-126 [Abstract] [Full Text]  
  • Garrity-Ryan, L., Kazmierczak, B., Kowal, R., Comolli, J., Hauser, A., Engel, J. N. (2000). The Arginine Finger Domain of ExoT Contributes to Actin Cytoskeleton Disruption and Inhibition of Internalization of Pseudomonas aeruginosa by Epithelial Cells and Macrophages. Infect. Immun. 68: 7100-7113 [Abstract] [Full Text]  
  • Krall, R., Schmidt, G., Aktories, K., Barbieri, J. T. (2000). Pseudomonas aeruginosa ExoT Is a Rho GTPase-Activating Protein. Infect. Immun. 68: 6066-6068 [Abstract] [Full Text]  
  • Kaufman, M. R., Jia, J., Zeng, L., Ha, U., Chow, M., Jin, S. (2000). Pseudomonas aeruginosa mediated apoptosis requires the ADP-ribosylating activity of ExoS. Microbiology 146: 2531-2541 [Abstract] [Full Text]  
  • Allewelt, M., Coleman, F. T., Grout, M., Priebe, G. P., Pier, G. B. (2000). Acquisition of Expression of the Pseudomonas aeruginosa ExoU Cytotoxin Leads to Increased Bacterial Virulence in a Murine Model of Acute Pneumonia and Systemic Spread. Infect. Immun. 68: 3998-4004 [Abstract] [Full Text]  
  • Dacheux, D., Toussaint, B., Richard, M., Brochier, G., Croize, J., Attree, I. (2000). Pseudomonas aeruginosa Cystic Fibrosis Isolates Induce Rapid, Type III Secretion-Dependent, but ExoU-Independent, Oncosis of Macrophages and Polymorphonuclear Neutrophils. Infect. Immun. 68: 2916-2924 [Abstract] [Full Text]  
  • Cowell, B. A., Chen, D. Y., Frank, D. W., Vallis, A. J., Fleiszig, S. M. J. (2000). ExoT of Cytotoxic Pseudomonas aeruginosa Prevents Uptake by Corneal Epithelial Cells. Infect. Immun. 68: 403-406 [Abstract] [Full Text]  
  • Dacheux, D., Attree, I., Schneider, C., Toussaint, B. (1999). Cell Death of Human Polymorphonuclear Neutrophils Induced by a Pseudomonas aeruginosa Cystic Fibrosis Isolate Requires a Functional Type III Secretion System. Infect. Immun. 67: 6164-6167 [Abstract] [Full Text]  
  • Mukhopadhyay, S., Kapatral, V., Xu, W., Chakrabarty, A. M. (1999). Characterization of a Hank's Type Serine/Threonine Kinase and Serine/Threonine Phosphoprotein Phosphatase in Pseudomonas aeruginosa. J. Bacteriol. 181: 6615-6622 [Abstract] [Full Text]  
  • Olson, J. C., Fraylick, J. E., McGuffie, E. M., Dolan, K. M., Yahr, T. L., Frank, D. W., Vincent, T. S. (1999). Interruption of Multiple Cellular Processes in HT-29 Epithelial Cells by Pseudomonas aeruginosa Exoenzyme S. Infect. Immun. 67: 2847-2854 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vallis, A. J.
Right arrow Articles by Frank, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vallis, A. J.
Right arrow Articles by Frank, D. W.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»